Rare partnership targets fault lines in fragmented health system

Marking Rare Cancers Awareness Day (26 June), Christine Cockburn, CEO of Rare Cancers Australia (RCA) and Dr Brindan Suresh, Group Executive Health & Strategy at Ramsay Health Care, join the Health Industry Hub podcast to spotlight a rare partnership that is ‘truly game-changing’ for patients diagnosed with a rare cancer.

Drawing on his experience as a clinician and healthcare leader, Dr Suresh reflects on the gaps that remain across the cancer care journey, including the complexities patients face when seeking the right expertise, treatment options, and support. The conversation examines how these challenges look different across public and private healthcare settings, and what needs to change to improve outcomes.

Cockburn brings the policy lens into sharper focus, particularly when examining whether recent federal budget decisions have altered the terrain in any meaningful way. The implication extends beyond funding, to whether rare cancers remain structurally peripheral within national policy priorities, or whether that positioning is beginning to shift.

At the centre of the discussion sits a new partnership between RCA, Ramsay Health Care and GenesisCare. It is presented not as a symbolic alignment, but as a deliberate attempt to extend reach and impact in patient care.

Looking ahead, the conversation explores the forces expected to shape rare cancer care over the next five years as well as the priorities Rare Cancers Australia is taking forward in its engagement with governments.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.